 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Neurological Complications & HIV
General
- Neurological Complications of AIDS Fact Sheet (August 29, 2007)
From U.S. National Institutes of Health - Headache and HIV (Winter 2004/2005)
Gregory Pauxtis, M.D., discusses potential causes and treatments for headaches in people with HIV.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Neurological Complications of HIV/AIDS (Winter 2004/2005)
A clinical review by Venkat K. Rao, M.D., and Florian P. Thomas, M.D., M.A., Ph.D.
To read PDF, click here
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - Neurologic Complications in HIV-Infected Children and Adolescents (March 2003)
To read PDF, click here
From New York State Department of Health AIDS Institute - The Central Nervous System and HIV (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project
Research
- Literature Citations for the Diagnosis of Neurological Complications in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Etiology of Neurological Complications in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - Literature Citations for the Treatment of Neurological Complications in HIV-Infected Patients (Regularly Updated)
From U.S. National Institutes of Health - HIV-Positive On HAART Less Likely to Experience Brain Damage, Study Says (October 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HAART May Help Protect HIV-Infected Patients From Neurodegeneration, Study Says (October 9, 2007)
In Neurology - HIV Suppression by HAART Preserves Cognitive Function in Advanced, Immune-Reconstituted AIDS Patients (May 31, 2007)
In AIDS - HIV JournalView: Efavirenz Has No Significant, Lasting Impact on Neuropsychological Performance (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO - Higher Efavirenz Plasma Levels May Increase Neuropsychiatric Complication Risk (December 15, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - AIDS Reduces Brain Tissue in Certain Regions Despite HAART, Study Says (October 12, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Meth Use, HIV Infection Linked to Changes in Brain Structure That Can Impair Cognitive Functions, Study Says (August 15, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Minocycline May Have Protective Effect Against HIV-Related Neurological Complications, Research Suggests (July/August 2005)
Intriguing findings reported in SIV-infected monkeys receiving this inexpensive antibiotic.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - Neuropsychiatric Symptoms From Efavirenz Not Always Time-Limited (May/June 2005)
More than half of 120 Spanish patients report persistent, though usually mild, symptoms after nearly two years.
From The Body PRO - The Genomics of Efavirenz Toxicity (January 2005)
Part of HIV JournalView's Top 10 Research Reports of 2004.
In The 12th International AIDS Conference, from The Body PRO - Previous Alcohol Abuse May Reduce HIV Patients' Cognitive Function (March 18, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Neurologic Side Effects of Efavirenz Not Affected by the Drug's Blood Levels (March/April 2004)
In Positively Aware, from Test Positive Aware Network - HIVers Over 50 at Increased Risk of Cognitive Impairment, Even With HAART (February 19, 2004)
From aidsmap.com - Dementia: Brain Damage Found in HIV Patients on Antiretroviral Therapy (January 16, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Acquired Immunodeficiency Syndrome and the Risk of Stroke (December 18, 2003)
Abstract of a U.S. study finding a greatly increased likelihood of stroke among AIDS patients.
In Stroke - Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion (November 2003)
Abstract of a study in the Archives of Neurology.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - ACTG 5097s: Efavirenz-Related CNS Events in the 5095 Study (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Memory Problems Increase Patients' Wish to Die (June 13, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Efavirenz More Durable Than Nevirapine, But CNS Toxicity Underestimated (April 29, 2003)
British researchers find that efavirenz works better over the long term, but that its psychiatric side effects persist a lot longer than previously thought.
From aidsmap.com - Psychiatric and Neuropsychiatric Manifestations of HIV Infection (April 4, 2003)
A slide presentation by Ewald Horwath, M.D.
- HIV Infection May Trigger Neurologic Disorder (January/February 2002)
In Body Positive, from Body Positive - Anemia Symposium Discusses Relationship With HIV, Cancer, Hepatitis C; Discusses Erythropoietin Use (December 16, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Cerebrospinal Fluid HIV-1 RNA Levels Peak During Primary HIV-1 Infection (February 5, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
  |
  |